Table 2.
Acute GVHD, TRM, relapse, fungal infection and AKI during the first 100 days
| CYP3A5 genotype | *1/*1 or *1/*3 (n = 11) | *3/*3 (n = 13) | P value |
|---|---|---|---|
| Acute GVHD | 0.173 | ||
| Grade 0 | 5 | 8 | |
| Grade 1 | 1 | 1 | |
| Grade 2 | 1 | 4 | |
| Grade 3 | 3 | 0 | |
| Grade 4 | 1 | 0 | |
| Acute GVHD | 0.017 | ||
| Grade 0–2 | 7 | 13 | |
| Grade 3–4 | 4 | 0 | |
| TRM | 0 | 0 | |
| Relapse | 1 | 1 | 0.902 |
| Fungal infection | 1 | 1 | 0.902 |
| AKI | 1 | 6 | 0.046 |
GVHD graft-versus-host disease, TRM transplantation-related-mortality, AKI acute kidney injury